E. Tsakalaki

Association of BRCA1, ERCC1, RAP80, PKM2, RRM1, RRM2, TS, TSP1, and TXR1 mRNA expression levels between primary tumors and infiltrated regional lymph nodes in patients with resectable non-small cell lung cancer

E. Stathopoulos, J. Souglakos, J. Menis, 2018, The Pharmacogenomics Journal.

Tumoral Expression of TXR1 and TSP1 Predicts Overall Survival of Patients with Lung Adenocarcinoma Treated with First-line Docetaxel-Gemcitabine Regimen

D. Mavroudis, V. Georgoulias, E. Stathopoulos, 2009, Clinical Cancer Research.

PKM2 as a biomarker for chemosensitivity to front-line platinum-based chemotherapy in patients with metastatic non-small-cell lung cancer

Georgios S. Ioannidis, A. Voutsina, D. Mavroudis, 2014, British Journal of Cancer.

Impact of KRAS, BRAF, PIK3CA Mutations, PTEN, AREG, EREG Expression and Skin Rash in ≥2nd Line Cetuximab-Based Therapy of Colorectal Cancer Patients

M. Tzardi, D. Mavroudis, V. Georgoulias, 2011, PloS one.

A seismotectonic study for the Heraklion basin in Crete ( Southern Hellenic Arc , Greece )

A. Sarris, F. Vallianatos, E. Kokinou, 2009 .

Long-term clinical benefit from salvage EGFR tyrosine kinase inhibitors in advanced non-small-cell lung cancer patients with EGFR wild-type tumors

V. Georgoulias, A. Voutsina, E Lagoudaki, 2018, Clinical and Translational Oncology.

Association of BRCA1, ERCC1, RAP80, PKM2, RRM1, RRM2, TS, TSP1, and TXR1 mRNA expression levels between primary tumors and infiltrated regional lymph nodes in patients with resectable non-small cell lung cancer

E. Stathopoulos, V. Georgoulias, J. Souglakos, 2019, The Pharmacogenomics Journal.

LKB1 Loss Correlates with STING Loss and, in Cooperation with β-Catenin Membranous Loss, Indicates Poor Prognosis in Patients with Operable Non-Small Cell Lung Cancer

V. Georgoulias, K. Marias, A. Voutsina, 2024, Cancers.